Home/Viral Hepatitis (A, B, C)
Condition Deep-Dive

Viral Hepatitis (A, B, C)

Liver inflammation from hepatitis A (acute, foodborne), B (often chronic when caught in infancy) or C (often chronic, now curable with antivirals). Nutrition supports the liver through treatment: adequate protein, coffee and no alcohol. Milk thistle has not been shown to change the disease course.

Liver, Gallbladder & Pancreas Evidence-Based

Last updated:

โš ๏ธ Medication safety: please read first. The nutrition and supplement approaches on this page are meant to work alongside your prescribed treatment, never to replace it. Never stop, reduce or change your hepatitis medication without your prescriber's guidance. Doing so can be dangerous. Several supplements interact with hepatitis medication or can harm the liver, so talk to your prescriber or pharmacist before starting anything on this page.
Definition

What Is Viral Hepatitis?

Viral hepatitis is liver inflammation caused by one of five distinct hepatitis viruses (A, B, C, D, E). The three most important globally are hepatitis A (acute, foodborne, self-limiting), hepatitis B (can cause acute and chronic infection, vaccine-preventable) and hepatitis C (often chronic, but now curable with direct-acting antivirals, known as DAAs).

Acute viral hepatitis presents with jaundice, fatigue, nausea and elevated liver enzymes. Most cases of hepatitis A and many cases of hepatitis B resolve spontaneously. Hepatitis C usually causes no symptoms when first caught, and about 70% of people infected develop long-term infection.9

Chronic hepatitis B and C are leading causes of cirrhosis and hepatocellular carcinoma globally: hepatitis B accounts for about a third of liver cancer cases and hepatitis C for more than a fifth.13 Modern antiviral therapy has changed the outlook: hepatitis C is now curable in over 95% of patients with 8 to 12 weeks of oral DAAs; hepatitis B can be suppressed (though rarely cured)3 with long-term antivirals.

๐Ÿ’ก Key Insight: Hepatitis C is curable. CDC recommends that all adults be tested at least once, and more often with ongoing risk such as injection drug use. A simple antibody test followed by RNA confirmation, then 8 to 12 weeks of direct-acting antivirals (glecaprevir/​pibrentasvir, sofosbuvir/​velpatasvir, ledipasvir/​sofosbuvir) cures the infection.2
A torso with the liver, three round viruses labeled hepatitis A, B and C, and a short list: inflammation of the liver; spread by contaminated food or water, blood or body fluids; fever, fatigue and nausea; jaundice

The Three Major Hepatitis Viruses

๐Ÿฝ๏ธ Hepatitis A (HAV)

Fecal-oral transmission1 (contaminated food/water, poor sanitation). Acute illness, no chronic form. Almost everyone recovers fully, though rarely it causes acute liver failure12. Vaccine-preventable. Common in travelers to endemic areas. Lifelong immunity after infection.

๐Ÿ’‰ Hepatitis B (HBV)

Blood/​sexual/​perinatal transmission. Fewer than 5% of adults who catch it develop chronic infection, against about 95% of infants and young children8. Chronic HBV increases cirrhosis and liver cancer risk. Vaccine-preventable. Treatable with antivirals (tenofovir, entecavir).

๐Ÿฉธ Hepatitis C (HCV)

Bloodborne (mainly IV drug use, pre-⁠1992 transfusions). About 70% become chronic9. No vaccine yet. Curable in over 95% with 8 to 12 weeks of oral DAAs9. Major cause of liver cancer historically.

By the Numbers

Viral Hepatitis by the Numbers

~240M
people worldwide live with chronic hepatitis B8
~47M
people worldwide live with chronic hepatitis C9
>95%
of people with chronic hepatitis C are clear of the virus after 8 to 12 weeks of prescribed antiviral tablets, which is what it means to say hepatitis C is curable2
~1.1M
deaths a year worldwide from hepatitis B, mostly from cirrhosis and liver cancer8
27%
of people living with hepatitis B worldwide knew they had it, which is why testing, not symptoms, is what finds it10
All adults
are advised to have a hepatitis C test and a hepatitis B test at least once, with testing in every pregnancy and for anyone who asks11
Signs & Symptoms

Symptoms of Viral Hepatitis

Acute hepatitis has a characteristic prodrome followed by jaundice. Chronic infections are often asymptomatic until advanced liver disease develops.

SymptomWhat happens
Acute Hepatitis
Profound FatigueOften the earliest and most prominent symptom. Severe, disabling. Lasts weeks to months. May persist after biochemical recovery.
JaundiceYellow eyes/skin (sclera first), dark cola-colored urine, pale clay-colored stools. Develops as bilirubin rises. Does not appear in every case.
Anorexia, Nausea, VomitingSevere loss of appetite, particularly aversion to fatty foods and cigarettes (in smokers). Nausea and vomiting common. Weight loss.
Right Upper Quadrant DiscomfortDull ache from inflamed liver stretching its capsule. Not the sharp pain of biliary disease. Hepatomegaly often palpable.
Chronic Hepatitis B/C
Often Asymptomatic for DecadesThe dangerous reality of chronic HBV and HCV: both can stay silent for years. Hepatitis C often causes no symptoms until decades after infection, when serious liver damage has developed, and 15 to 30% of people with it develop cirrhosis within 20 years.9 This is why screening is critical.
Chronic FatigueThe most common symptom when present. Disproportionate to liver enzyme levels. Significantly impacts quality of life.
Joint Pain (Arthralgia)Common with chronic HCV. Polyarthralgia involving small joints. Sometimes precedes other symptoms. May be mistaken for early rheumatoid arthritis.
Signs of Advanced Disease (Cirrhosis)Late presentation: ascites, jaundice, varices, hepatic encephalopathy, palmar erythema, spider angiomas. Indicates progression to cirrhosis, so see your doctor promptly; get emergency care for confusion or drowsiness, vomiting blood or black tarry stools, and an urgent appointment for yellow skin or eyes or a swelling abdomen.
Causes

Causes of Viral Hepatitis

Viral hepatitis is an infection, not a dietary or lifestyle condition. Each type is caused by a specific virus with its own route of transmission, and which virus it is decides everything that follows, from whether it clears by itself to whether there is a vaccine or a course of tablets that ends it1289.

CauseHow It Contributes to Viral HepatitisWhat Helps
The hepatitis A virus, in contaminated food or waterSpread when someone swallows food or water contaminated with the feces of an infected person, and tied to unsafe water and poor sanitation and hygiene; it causes short-term illness only, and almost everyone recovers with lifelong immunity, though rarely it causes acute liver failure12A safe and effective vaccine; safe water and food hygiene; supportive medical care, since there is no antiviral for hepatitis A12
The hepatitis B virus, passed from mother to child or caught in early childhoodIn areas where hepatitis B is common this is the usual route, and it matters because infection in infancy or early childhood becomes long-term in about 95% of cases, against less than 5% when it is caught in adulthood8The hepatitis B vaccine within 24 hours of birth then the rest of the course, which offers nearly 100% protection; antiviral medicine in pregnancy to prevent transmission; a hepatitis B test in every pregnancy8
The hepatitis B virus, through blood and body fluidsSpread by needlestick injury, tattooing, piercing, sharing or reusing contaminated needles and syringes, and sex with an infected partner, more so in people who are not vaccinated8Vaccination if not already immune; not sharing injecting, tattooing or piercing equipment; condoms; a hepatitis B test at least once for every adult, since most people have no symptoms811
The hepatitis C virus, through bloodSpread mainly by sharing needles and syringes, unsafe injections and procedures in health care, and unscreened transfusions; around 30% of people clear it within 6 months and the rest are left with a long-term infection that usually causes no symptoms for decades9An antibody test, then a test for the virus itself if that is positive; prescribed antiviral tablets, which are the treatment that changes what happens next; not sharing needles or personal items such as razors, toothbrushes or nail clippers911
Not being vaccinated, or an incomplete courseHepatitis A and hepatitis B are both vaccine-preventable, and the hepatitis B vaccine protects for at least 20 years, but all three shots are needed, so a part-finished course leaves people open to infection812Checking immunity and finishing the course; there is no vaccine for hepatitis C, so testing and prescribed treatment take its place9
Alcohol alongside a long-term infectionAlcohol is not how anyone catches viral hepatitis, but alcohol and chronic viral hepatitis together accelerate scarring substantially more than either alone4Complete abstinence during and after treatment, the most valuable dietary change; alcohol heads the "Strictly Avoid" list in the diet section
Diagnosis

How Viral Hepatitis Is Diagnosed

TestWhat it shows
Serologic Diagnosis
Hepatitis AAnti-HAV IgM, positive in acute infection. Anti-HAV IgG, positive after recovery or vaccination (immunity). Total Anti-HAV, combination.
Hepatitis B PanelHBsAg: active infection (acute or chronic). Anti-HBs: immunity (recovery or vaccine). Anti-HBc IgM: recent infection. Anti-HBc IgG: past or chronic. HBeAg + HBV DNA: viral replication/​activity.
Hepatitis CAnti-HCV antibody: screening test (positive = ever exposed). HCV RNA (PCR): confirms active infection (positive = currently infected). HCV genotype: guides treatment selection.
Disease Assessment
Liver Function TestsAST, ALT (acute: often >1,000; chronic: mildly elevated or normal). Alkaline phosphatase, bilirubin, albumin, INR (synthetic function markers).
Transient Elastography (Liver Stiffness Scan)Non-invasive measurement of liver stiffness, stages fibrosis. Replaces biopsy in most cases. Critical for chronic HBV/HCV staging.
FIB-⁠4 & APRI ScoresBlood-based non-invasive fibrosis scores. Use AST, ALT, platelet count, age. Free, accessible, useful first-line.
Ultrasound + AFP (HCC Screening)Every 6 months for cirrhotic patients or chronic HBV, surveillance for hepatocellular carcinoma. Alpha-fetoprotein blood test paired with imaging.
Treatment Comparison

Conventional and Holistic Treatment for Viral Hepatitis

๐ŸŒฟ HOLISTIC
๐Ÿ’Š CONVENTIONAL
๐ŸŒฟ

Holistic / Functional Approach

Supportive for acute hepatitis; complementary for chronic. Hepatitis C should be cured with DAAs first.

Acute Hepatitis A/B
Supportive, rest, hydration, nutrition; most resolve spontaneously
Chronic Hepatitis B
Antiviral therapy + lifestyle to slow fibrosis. Holistic complements, doesn't replace.
Chronic Hepatitis C
Curable with direct-acting antivirals (8 to 12 weeks), which come first; liver-supportive nutrition follows2
Liver Regeneration
Adequate protein and no alcohol support recovery; milk thistle has not been shown to change the disease course

Full Holistic Approach Includes

  • Strict alcohol abstinence. Alcohol and viral hepatitis together accelerate fibrosis substantially more than either alone.
  • Avoid hepatotoxic drugs, limit acetaminophen (<2 g/day), avoid unnecessary medications, check drug interactions
  • Adequate protein, 1 to 1.5 g/kg/day for hepatocyte regeneration; do not cut protein without your liver specialist's advice
  • Mediterranean diet, anti-inflammatory, antioxidant-rich, supports liver health
  • Milk thistle (silymarin)5, well tolerated but not recommended: a randomized trial in chronic hepatitis C found no fall in ALT
  • NAC 600 to 1,800 mg/day, glutathione precursor; not shown to help viral hepatitis
  • Alpha-lipoic acid 300 to 600 mg/day, an antioxidant; not shown to help viral hepatitis
  • Vitamin D, deficiency common; correct it with your clinician.
  • Selenium 200 mcg/day, antioxidant cofactor; levels can be low in liver disease
  • Coffee 2 to 3 cups/day, associated with less fibrosis progression in cohort studies6
  • Vaccinate against HAV + HBV if not already immune, prevents super-infection
  • HCC surveillance, every 6 months if cirrhotic or chronic HBV.
โš ๏ธ Important: If you have hepatitis C, the most "natural" thing you can do is get cured. Modern DAAs cure over 95% with minimal side effects. Don't pursue holistic-only approaches for chronic HCV when cure is available. After treatment, the nutrition strategies here support liver health.
Supplement Protocol

Evidence-Based Supplements for Viral Hepatitis

Liver-supportive supplements complement but don't replace antiviral therapy. For HCV, prioritize getting cured with DAAs.

SupplementWhat it is forTypical rangeTimingNotes & cautions
Milk Thistle (Silymarin)Widely used and well tolerated. A randomized trial in chronic hepatitis C found no fall in ALT, and it has not been shown to clear virus or change progression5.Not recommended for hepatitis C (the trial used 420 or 700 mg three times a day)Not applicableIt is not a reason to delay curative treatment.
N-Acetyl Cysteine (NAC)Glutathione precursor (the body uses it to make the antioxidant glutathione). Not shown to help viral hepatitis.600 to 1,800 mg/dayDivided dosesAlso protects against acetaminophen toxicity.
Alpha-Lipoic AcidAn antioxidant that helps recycle others (vitamin C, E, glutathione). Not shown to help viral hepatitis.300 to 600 mg/dayEmpty stomachR-form better absorbed. May lower blood sugar.
Vitamin D3Deficiency is common in chronic liver disease; correct it with your clinician.Set the dose with your clinician; most adults need no blood test firstWith fat mealPair with K2 200 mcg; vitamin K can interfere with warfarin, so check first if you take a blood thinner.
SeleniumCofactor for glutathione peroxidase, an antioxidant enzyme; levels can be low in chronic liver disease. Not shown to help viral hepatitis.200 mcg/dayWith foodDon't exceed 400 mcg/day long-term.
Vitamin E (Mixed Tocopherols)Antioxidant; some evidence for reducing fibrosis in chronic hepatitis (especially with steatosis).400 to 800 IU/dayWith fat mealUse mixed tocopherols, not alpha-tocopherol alone. Agree on it with your specialist first: in a large trial of healthy men, 400 IU a day raised prostate cancer risk, and high doses can raise bleeding risk with blood thinners14.
Glycyrrhizin (Licorice Root)Anti-inflammatory, antiviral effects. Used IV in Japan for chronic hepatitis. Reduces ALT levels.150 to 300 mg/day, and only with a clinicianWith mealsCaution: raises blood pressure and lowers potassium, and some people are affected at low intakes. DGL is not a substitute here, because deglycyrrhizinated licorice has the glycyrrhizin removed and cannot produce the ALT-lowering effect. Needs blood pressure and potassium monitoring. It makes the body hold on to salt and water, so it is not for people with cirrhosis, fluid buildup (swelling or a swollen abdomen), high blood pressure, or heart or kidney disease.
Curcumin (Turmeric)Not shown to help viral hepatitis: anti-inflammatory and antifibrotic only in laboratory work, and liver injury has been reported (see the caution).500 to 1,500 mg/dayWith fat mealLiver damage has been reported with high-absorption curcumin products, so on a liver condition agree on it with your specialist first, and stop and seek advice if you notice fatigue, nausea, poor appetite, dark urine or yellowing of the skin or eyes15.
What to Expect

What to Expect Over Time

What happens depends on the virus and, for hepatitis B and C, on treatment.

Treatment and supportive care, together
First Weeks

Testing matters because long-term hepatitis B and C usually cause no symptoms for decades. Hepatitis C and hepatitis B tests are advised at least once for every adult, in every pregnancy, at ongoing risk and on request.

Months 1 to 3

Long-term hepatitis C is treated with 8 to 12 weeks of prescribed antiviral tablets, leaving more than 95% of people clear of the virus. Hepatitis B tablets hold the virus down rather than clear it; most stay on them for life, and stopping without the specialist can set off a severe flare3.

Months 3 to 12

Food does not clear either virus; nutrition works around treatment: no alcohol, adequate protein, no iron supplements without a documented deficiency6. A blood test after treatment confirms the virus is gone2.

Long Term

Treatment changes the outcome: untreated, hepatitis B and C are leading causes of cirrhosis and liver cancer. Hepatitis B tablets slow cirrhosis, reduce liver cancer and improve survival; clearing hepatitis C lowers liver cancer risk, though checks every six months continue for anyone with cirrhosis2.

When to Seek Care

Get emergency care for confusion or drowsiness, vomiting blood or black tarry stools. Ask for an urgent appointment for yellow skin or eyes, dark urine, pale stools, persistent vomiting or a swelling abdomen. Never stop hepatitis B tablets without the specialist who prescribed them, and tell any doctor planning immune-lowering treatment, including corticosteroids, that you have or have had hepatitis B: it can reactivate3.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Next Steps

Get Tested. Get Treated. Get Cured.

Hepatitis C is curable. Hepatitis B is treatable. Hepatitis A is preventable. Don't let chronic viral hepatitis silently destroy your liver: get screened, address risk factors and access modern antiviral therapy. Holistic strategies complement, never replace, evidence-based antiviral treatment.

Explore Cirrhosis โ†’ Explore Liver Cancer โ†’

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.7 The most important thing on this page is short: hepatitis C is curable, in more than 95% of people, with 8 to 12 weeks of well-tolerated oral tablets. If you have it, or might have it, get tested and treated. No supplement regimen is a reasonable alternative. Hepatitis B is different: it is usually suppressed rather than cured, treatment is long-term, and stopping antivirals abruptly can cause a dangerous flare, so that is never a self-directed decision. Hepatitis A and B are both vaccine-preventable, and vaccination is recommended for anyone with chronic liver disease. Nutrition supports the liver through and after treatment; it does not clear a virus.

  1. On the three viruses: hepatitis A is fecally transmitted, usually self-limiting and vaccine-preventable. Hepatitis B is blood and body-fluid transmitted, becomes chronic more often when acquired in infancy, is vaccine-preventable and carries hepatocellular carcinoma risk even without cirrhosis. Hepatitis C is bloodborne, becomes chronic in most people and is now curable. ↩
  2. On hepatitis C cure. Direct-acting antiviral regimens are reported to achieve sustained virologic response, meaning cure, in over 95% of patients with 8 to 12 weeks of oral therapy, across genotypes and including people with cirrhosis. Cure reduces but does not eliminate hepatocellular carcinoma risk in those with established cirrhosis, so surveillance continues after cure. Reinfection is possible, so ongoing risk reduction still matters. ↩
  3. On hepatitis B, and why stopping treatment is dangerous. Nucleoside and nucleotide analogs suppress viral replication and reduce progression and cancer risk, but rarely eradicate the virus. Discontinuing therapy can precipitate a severe hepatitis flare and hepatic decompensation; severe flares after antiviral withdrawal are documented, PubMed 42019867, and stopping is a decision made and monitored by a specialist. Immunosuppressive treatment, including corticosteroids and rituximab, can reactivate hepatitis B, which is why screening before immunosuppression is standard. ↩
  4. On alcohol: alcohol and chronic viral hepatitis together accelerate fibrosis substantially more than either alone. Abstinence is the single most valuable dietary change during and after treatment. ↩
  5. On milk thistle: silymarin is widely used and generally well tolerated, and it is worth being clear about the evidence. A randomized controlled trial of higher-dose oral silymarin (420 or 700 mg three times a day for 24 weeks) in chronic hepatitis C, published in JAMA in 2012, did not reduce serum ALT compared with placebo, PubMed 22797645. It has not been shown to clear virus or to change disease progression. It is not a reason to delay curative treatment. ↩
  6. On liver-supportive eating: coffee consumption is associated with lower liver enzymes, less fibrosis progression and lower hepatocellular carcinoma risk across multiple cohorts: a meta-analysis found roughly 40% lower hepatocellular carcinoma risk for any coffee consumption versus none, while noting reverse causation may explain part of the association, PubMed 23660416. It is one of the more consistent dietary findings in hepatology. Adequate protein supports regeneration. Avoid iron supplements without documented deficiency, since iron accumulation worsens liver injury. ↩
  7. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic. ↩
  8. On hepatitis B: WHO estimates 240 million people were living with long-term hepatitis B in 2024 and that it caused about 1.1 million deaths that year, mostly from cirrhosis and liver cancer. It is most often passed from mother to child at birth or in early childhood, and also through blood and body fluids; infection in infancy becomes long-term in about 95% of cases against less than 5% in adults. The vaccine given within 24 hours of birth and completed with later doses offers nearly 100% protection and lasts at least 20 years. Antiviral medicines can slow the advance of cirrhosis, reduce cases of liver cancer and improve long-term survival, and most people who start them continue for life, WHO. ↩
  9. On hepatitis C: WHO estimates 47 million people have long-term hepatitis C worldwide. Around 30% of people clear the virus without treatment within 6 months and the remaining 70% develop long-term infection. New infections are usually without symptoms, and long-term infection often stays silent until decades later, when serious liver damage has developed; 15 to 30% of people with long-term hepatitis C develop cirrhosis within 20 years. There is no vaccine, but direct-acting antiviral medicines taken for 8 to 12 weeks clear the virus in more than 95% of people, and diagnosis is a two-step process of an antibody test followed by a test for the virus itself, WHO. ↩
  10. On how many people know they have it: as of 2024, 65 million people (27% of those estimated to be living with hepatitis B worldwide) were aware of their infection status; only about 4.3% of people with chronic hepatitis B were on antiviral treatment, WHO. ↩
  11. On who is offered testing: doctors typically recommend a hepatitis C test for all adults at least once in their life, in every pregnancy, for people at risk and for anyone who asks. They recommend a hepatitis B test for all adults at least once in their lifetime, in every pregnancy, for infants born to someone with hepatitis B and for anyone who asks, CDC, hepatitis C testing, CDC, hepatitis B testing. ↩
  12. On hepatitis A: it is spread when someone swallows food or water contaminated with the feces of an infected person, and the risk is tied to unsafe water, poor sanitation and poor hand hygiene. It does not cause long-term liver disease. Almost everyone recovers with lifelong immunity; a very small proportion develop acute liver failure. A safe and effective vaccine prevents it, WHO. ↩
  13. On how much liver cancer the two viruses cause: a 2026 systematic review describes hepatitis B as the leading cause of liver cancer worldwide, responsible for one third of all cases, with hepatitis C accounting for more than 20%, PubMed 42605247. ↩
  14. On the risks of vitamin E supplements: in a trial of 35,533 relatively healthy men, 400 IU a day of vitamin E significantly increased the risk of prostate cancer against placebo, PubMed 21990298; and high doses may interfere with vitamin K and raise the risk of bleeding, which matters most for people taking blood thinners, Linus Pauling Institute, vitamin E. ↩
  15. On the safety of turmeric and curcumin: the NIH National Center for Complementary and Integrative Health reports that liver damage has been reported in some people taking curcumin products made to be more easily absorbed, and advises stopping them at once and talking with a clinician if symptoms such as fatigue, nausea, poor appetite, dark urine or jaundice appear, NCCIH, turmeric. ↩
  16. On who should get the hepatitis B vaccine: CDC's immunization advisers recommend hepatitis B vaccination for all infants, unvaccinated children younger than 19, all adults aged 19 to 59 and adults 60 and older with risk factors for hepatitis B, and say adults 60 and older without known risk factors may also receive it, CDC, hepatitis B vaccine administration. ↩